Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
13,253
archived clinical trials in
Arthritis

A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  1/22/2014
Clinical Research Facility
mi
from
Huntsville, AL
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 1/22/2014
Clinical Research Facility
mi
from
Huntsville, AL
Click here to add this to my saved trials
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  1/22/2014
Clinical Research Facility
mi
from
Hot Springs, AR
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 1/22/2014
Clinical Research Facility
mi
from
Hot Springs, AR
Click here to add this to my saved trials
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  1/22/2014
Clinical Research Facility
mi
from
Encino, CA
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 1/22/2014
Clinical Research Facility
mi
from
Encino, CA
Click here to add this to my saved trials
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  1/22/2014
Clinical Research Facility
mi
from
Lomita, CA
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 1/22/2014
Clinical Research Facility
mi
from
Lomita, CA
Click here to add this to my saved trials
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  1/22/2014
Clinical Research Facility
mi
from
Upland, CA
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 1/22/2014
Clinical Research Facility
mi
from
Upland, CA
Click here to add this to my saved trials
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  1/22/2014
Clinical Research Facility
mi
from
Brandon, FL
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 1/22/2014
Clinical Research Facility
mi
from
Brandon, FL
Click here to add this to my saved trials
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  1/22/2014
Clinical Research Facility
mi
from
Jacksonville, FL
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 1/22/2014
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  1/22/2014
Clinical Research Facility
mi
from
Lake Worth, FL
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 1/22/2014
Clinical Research Facility
mi
from
Lake Worth, FL
Click here to add this to my saved trials
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  1/22/2014
Clinical Research Facility
mi
from
Plant City, FL
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 1/22/2014
Clinical Research Facility
mi
from
Plant City, FL
Click here to add this to my saved trials
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  1/22/2014
Clinical Research Facility
mi
from
Summerfield, FL
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 1/22/2014
Clinical Research Facility
mi
from
Summerfield, FL
Click here to add this to my saved trials
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  1/22/2014
Clinical Research Facility
mi
from
Winter Haven, FL
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 1/22/2014
Clinical Research Facility
mi
from
Winter Haven, FL
Click here to add this to my saved trials
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  1/22/2014
Clinical Research Facility
mi
from
Evansville, IN
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 1/22/2014
Clinical Research Facility
mi
from
Evansville, IN
Click here to add this to my saved trials
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  1/22/2014
Clinical Research Facility
mi
from
Indianapolis, IN
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 1/22/2014
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  1/22/2014
Clinical Research Facility
mi
from
Elizabethtown, KY
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 1/22/2014
Clinical Research Facility
mi
from
Elizabethtown, KY
Click here to add this to my saved trials
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  1/22/2014
Clinical Research Facility
mi
from
Monroe, LA
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 1/22/2014
Clinical Research Facility
mi
from
Monroe, LA
Click here to add this to my saved trials
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  1/22/2014
Clinical Research Facility
mi
from
Worcester, MA
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 1/22/2014
Clinical Research Facility
mi
from
Worcester, MA
Click here to add this to my saved trials
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  1/22/2014
Clinical Research Facility
mi
from
Flowood, MS
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 1/22/2014
Clinical Research Facility
mi
from
Flowood, MS
Click here to add this to my saved trials
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  1/22/2014
Clinical Research Facility
mi
from
Las Cruces, NM
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 1/22/2014
Clinical Research Facility
mi
from
Las Cruces, NM
Click here to add this to my saved trials
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  1/22/2014
Clinical Research Facility
mi
from
Rochester, NY
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 1/22/2014
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  1/22/2014
Clinical Research Facility
mi
from
Duncansville, PA
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 1/22/2014
Clinical Research Facility
mi
from
Duncansville, PA
Click here to add this to my saved trials
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  1/22/2014
Clinical Research Facility
mi
from
Wyomissing, PA
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 1/22/2014
Clinical Research Facility
mi
from
Wyomissing, PA
Click here to add this to my saved trials
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  1/22/2014
Clinical Research Facility
mi
from
Dallas, TX
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 1/22/2014
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  1/22/2014
Clinical Research Facility
mi
from
Houston, TX
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 1/22/2014
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  1/22/2014
Clinical Research Facility
mi
from
West Jordan, UT
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK‑0663/Etoricoxib in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 1/22/2014
Clinical Research Facility
mi
from
West Jordan, UT
Click here to add this to my saved trials
Shoe Lifts for Leg Length Inequality in Adults With Knee or Hip Symptoms
Defining and Correcting Limb Length Inequality in Adults With Knee or Hip Symptoms
Status: Enrolling
Updated:  1/22/2014
UNC-CH Thurston Arthritis Research Center
mi
from
Smithfield, NC
Shoe Lifts for Leg Length Inequality in Adults With Knee or Hip Symptoms
Defining and Correcting Limb Length Inequality in Adults With Knee or Hip Symptoms
Status: Enrolling
Updated: 1/22/2014
UNC-CH Thurston Arthritis Research Center
mi
from
Smithfield, NC
Click here to add this to my saved trials
Prediction of Development of Scapular Notching Following Reverse Total Shoulder Arthroplasty
Prediction of Development of Scapular Notching Based on Glenosphere Positioning, Scapular Morphology, and Simulated Impingement-free Motion Using Three-dimensional Computed Tomography Analysis
Status: Enrolling
Updated:  1/30/2014
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Prediction of Development of Scapular Notching Following Reverse Total Shoulder Arthroplasty
Prediction of Development of Scapular Notching Based on Glenosphere Positioning, Scapular Morphology, and Simulated Impingement-free Motion Using Three-dimensional Computed Tomography Analysis
Status: Enrolling
Updated: 1/30/2014
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Duloxetine in Osteoarthritis (OA) Pain
Brain Morphometries in OA Patients Treated With Duloxetine
Status: Enrolling
Updated:  2/17/2014
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Duloxetine in Osteoarthritis (OA) Pain
Brain Morphometries in OA Patients Treated With Duloxetine
Status: Enrolling
Updated: 2/17/2014
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Topical Tranexamic Acid and Acute Blood Loss in Total Hip Arthroplasty
Topical Tranexamic Acid and Acute Blood Loss in Total Hip Arthroplasty
Status: Enrolling
Updated:  2/24/2014
Henry Ford Hospital
mi
from
Detroit, MI
Topical Tranexamic Acid and Acute Blood Loss in Total Hip Arthroplasty
Topical Tranexamic Acid and Acute Blood Loss in Total Hip Arthroplasty
Status: Enrolling
Updated: 2/24/2014
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Topical Tranexamic Acid and Acute Blood Loss in Total Hip Arthroplasty
Topical Tranexamic Acid and Acute Blood Loss in Total Hip Arthroplasty
Status: Enrolling
Updated:  2/24/2014
HFH Main campus
mi
from
Detroit, MI
Topical Tranexamic Acid and Acute Blood Loss in Total Hip Arthroplasty
Topical Tranexamic Acid and Acute Blood Loss in Total Hip Arthroplasty
Status: Enrolling
Updated: 2/24/2014
HFH Main campus
mi
from
Detroit, MI
Click here to add this to my saved trials
Sleep in Osteoarthritis Project
Sleep Disturbance, Central Pain Modulation, and Clinical Pain in Osteoarthritis (The SOAP Study)
Status: Enrolling
Updated:  3/10/2014
Johns Hopkins Bayview Medical Center 5510 Nathan Shock Dr, Ste 100
mi
from
Baltimore, MD
Sleep in Osteoarthritis Project
Sleep Disturbance, Central Pain Modulation, and Clinical Pain in Osteoarthritis (The SOAP Study)
Status: Enrolling
Updated: 3/10/2014
Johns Hopkins Bayview Medical Center 5510 Nathan Shock Dr, Ste 100
mi
from
Baltimore, MD
Click here to add this to my saved trials
AMPED Outcomes Registry of Post-ED Pain Management
Acute Management of Pain From the Emergency Department: A National, Emergency Department-Based Prospective Post-Intervention Registry of Non-Opioid and Opioid Management of Acute Pain
Status: Enrolling
Updated:  3/11/2014
LSU Medical Center
mi
from
New Orleans, LA
AMPED Outcomes Registry of Post-ED Pain Management
Acute Management of Pain From the Emergency Department: A National, Emergency Department-Based Prospective Post-Intervention Registry of Non-Opioid and Opioid Management of Acute Pain
Status: Enrolling
Updated: 3/11/2014
LSU Medical Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
AMPED Outcomes Registry of Post-ED Pain Management
Acute Management of Pain From the Emergency Department: A National, Emergency Department-Based Prospective Post-Intervention Registry of Non-Opioid and Opioid Management of Acute Pain
Status: Enrolling
Updated:  3/11/2014
University of Mississippi Medical Center
mi
from
Jackson, MS
AMPED Outcomes Registry of Post-ED Pain Management
Acute Management of Pain From the Emergency Department: A National, Emergency Department-Based Prospective Post-Intervention Registry of Non-Opioid and Opioid Management of Acute Pain
Status: Enrolling
Updated: 3/11/2014
University of Mississippi Medical Center
mi
from
Jackson, MS
Click here to add this to my saved trials
AMPED Outcomes Registry of Post-ED Pain Management
Acute Management of Pain From the Emergency Department: A National, Emergency Department-Based Prospective Post-Intervention Registry of Non-Opioid and Opioid Management of Acute Pain
Status: Enrolling
Updated:  3/11/2014
Cleveland Clinic
mi
from
Cleveland, OH
AMPED Outcomes Registry of Post-ED Pain Management
Acute Management of Pain From the Emergency Department: A National, Emergency Department-Based Prospective Post-Intervention Registry of Non-Opioid and Opioid Management of Acute Pain
Status: Enrolling
Updated: 3/11/2014
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
AMPED Outcomes Registry of Post-ED Pain Management
Acute Management of Pain From the Emergency Department: A National, Emergency Department-Based Prospective Post-Intervention Registry of Non-Opioid and Opioid Management of Acute Pain
Status: Enrolling
Updated:  3/11/2014
University of Oklahoma HSC
mi
from
Tulsa, OK
AMPED Outcomes Registry of Post-ED Pain Management
Acute Management of Pain From the Emergency Department: A National, Emergency Department-Based Prospective Post-Intervention Registry of Non-Opioid and Opioid Management of Acute Pain
Status: Enrolling
Updated: 3/11/2014
University of Oklahoma HSC
mi
from
Tulsa, OK
Click here to add this to my saved trials
AMPED Outcomes Registry of Post-ED Pain Management
Acute Management of Pain From the Emergency Department: A National, Emergency Department-Based Prospective Post-Intervention Registry of Non-Opioid and Opioid Management of Acute Pain
Status: Enrolling
Updated:  3/11/2014
Pennsylvania Hospital
mi
from
Philadelphia, PA
AMPED Outcomes Registry of Post-ED Pain Management
Acute Management of Pain From the Emergency Department: A National, Emergency Department-Based Prospective Post-Intervention Registry of Non-Opioid and Opioid Management of Acute Pain
Status: Enrolling
Updated: 3/11/2014
Pennsylvania Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
AMPED Outcomes Registry of Post-ED Pain Management
Acute Management of Pain From the Emergency Department: A National, Emergency Department-Based Prospective Post-Intervention Registry of Non-Opioid and Opioid Management of Acute Pain
Status: Enrolling
Updated:  3/11/2014
Thomas Jefferson University Hospital
mi
from
Philadelphia, PA
AMPED Outcomes Registry of Post-ED Pain Management
Acute Management of Pain From the Emergency Department: A National, Emergency Department-Based Prospective Post-Intervention Registry of Non-Opioid and Opioid Management of Acute Pain
Status: Enrolling
Updated: 3/11/2014
Thomas Jefferson University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
AMPED Outcomes Registry of Post-ED Pain Management
Acute Management of Pain From the Emergency Department: A National, Emergency Department-Based Prospective Post-Intervention Registry of Non-Opioid and Opioid Management of Acute Pain
Status: Enrolling
Updated:  3/11/2014
Medical University of South Carolina
mi
from
Charleston, SC
AMPED Outcomes Registry of Post-ED Pain Management
Acute Management of Pain From the Emergency Department: A National, Emergency Department-Based Prospective Post-Intervention Registry of Non-Opioid and Opioid Management of Acute Pain
Status: Enrolling
Updated: 3/11/2014
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
AMPED Outcomes Registry of Post-ED Pain Management
Acute Management of Pain From the Emergency Department: A National, Emergency Department-Based Prospective Post-Intervention Registry of Non-Opioid and Opioid Management of Acute Pain
Status: Enrolling
Updated:  3/11/2014
Medical University of South Carolina
mi
from
Charleston, SC
AMPED Outcomes Registry of Post-ED Pain Management
Acute Management of Pain From the Emergency Department: A National, Emergency Department-Based Prospective Post-Intervention Registry of Non-Opioid and Opioid Management of Acute Pain
Status: Enrolling
Updated: 3/11/2014
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
AMPED Outcomes Registry of Post-ED Pain Management
Acute Management of Pain From the Emergency Department: A National, Emergency Department-Based Prospective Post-Intervention Registry of Non-Opioid and Opioid Management of Acute Pain
Status: Enrolling
Updated:  3/11/2014
Ben Taub General Hospital
mi
from
Houston, TX
AMPED Outcomes Registry of Post-ED Pain Management
Acute Management of Pain From the Emergency Department: A National, Emergency Department-Based Prospective Post-Intervention Registry of Non-Opioid and Opioid Management of Acute Pain
Status: Enrolling
Updated: 3/11/2014
Ben Taub General Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
AMPED Outcomes Registry of Post-ED Pain Management
Acute Management of Pain From the Emergency Department: A National, Emergency Department-Based Prospective Post-Intervention Registry of Non-Opioid and Opioid Management of Acute Pain
Status: Enrolling
Updated:  3/11/2014
University of Texas HSC at Houston
mi
from
Houston, TX
AMPED Outcomes Registry of Post-ED Pain Management
Acute Management of Pain From the Emergency Department: A National, Emergency Department-Based Prospective Post-Intervention Registry of Non-Opioid and Opioid Management of Acute Pain
Status: Enrolling
Updated: 3/11/2014
University of Texas HSC at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
AMPED Outcomes Registry of Post-ED Pain Management
Acute Management of Pain From the Emergency Department: A National, Emergency Department-Based Prospective Post-Intervention Registry of Non-Opioid and Opioid Management of Acute Pain
Status: Enrolling
Updated:  3/11/2014
University of Alabama at Birmingham
mi
from
Birmingham, AL
AMPED Outcomes Registry of Post-ED Pain Management
Acute Management of Pain From the Emergency Department: A National, Emergency Department-Based Prospective Post-Intervention Registry of Non-Opioid and Opioid Management of Acute Pain
Status: Enrolling
Updated: 3/11/2014
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study of LY3090106 in Healthy Participants and Participants With Rheumatoid Arthritis (RA)
A Single-Dose, Multicenter, Dose-Escalation Study to Evaluate the Safety and Tolerability of LY3090106 in Healthy Subjects and Subjects With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/14/2014
Clinical Research Facility
mi
from
Baltimore, MD
A Study of LY3090106 in Healthy Participants and Participants With Rheumatoid Arthritis (RA)
A Single-Dose, Multicenter, Dose-Escalation Study to Evaluate the Safety and Tolerability of LY3090106 in Healthy Subjects and Subjects With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/14/2014
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
WebSMART: Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
Status: Enrolling
Updated:  3/18/2014
Children's Mercy Hospital
mi
from
Kansas City, MO
Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
WebSMART: Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
Status: Enrolling
Updated: 3/18/2014
Children's Mercy Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
WebSMART: Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
Status: Enrolling
Updated:  3/18/2014
Dell Children's Medical Center of Central Texas
mi
from
Austin, TX
Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
WebSMART: Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
Status: Enrolling
Updated: 3/18/2014
Dell Children's Medical Center of Central Texas
mi
from
Austin, TX
Click here to add this to my saved trials
Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
WebSMART: Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
Status: Enrolling
Updated:  3/18/2014
Duke Univ Med Ctr
mi
from
Durham, NC
Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
WebSMART: Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
Status: Enrolling
Updated: 3/18/2014
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
WebSMART: Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
Status: Enrolling
Updated:  3/18/2014
Joseph M. Sanzari Children's Hospital
mi
from
Hackensack, NJ
Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
WebSMART: Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
Status: Enrolling
Updated: 3/18/2014
Joseph M. Sanzari Children's Hospital
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
WebSMART: Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
Status: Enrolling
Updated:  3/18/2014
Lurie Children's Hospital
mi
from
Chicago, IL
Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
WebSMART: Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
Status: Enrolling
Updated: 3/18/2014
Lurie Children's Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
WebSMART: Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
Status: Enrolling
Updated:  3/18/2014
Nationwide Children's Hospital
mi
from
Columbus, OH
Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
WebSMART: Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
Status: Enrolling
Updated: 3/18/2014
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
WebSMART: Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
Status: Enrolling
Updated:  3/18/2014
Riley Hospital for Children
mi
from
Indianopolis, IN
Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
WebSMART: Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
Status: Enrolling
Updated: 3/18/2014
Riley Hospital for Children
mi
from
Indianopolis, IN
Click here to add this to my saved trials
Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
WebSMART: Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
Status: Enrolling
Updated:  3/18/2014
Seattle Children's Hospital
mi
from
Seattle, WA
Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
WebSMART: Efficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
Status: Enrolling
Updated: 3/18/2014
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials